US Bancorp’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.4K | Buy |
575
+156
| +37% | +$3.1K | ﹤0.01% | 3376 |
|
2025
Q1 | $7.08K | Buy |
419
+262
| +167% | +$4.43K | ﹤0.01% | 3537 |
|
2024
Q4 | $2.9K | Sell |
157
-344
| -69% | -$6.35K | ﹤0.01% | 3773 |
|
2024
Q3 | $10.9K | Sell |
501
-15
| -3% | -$326 | ﹤0.01% | 3338 |
|
2024
Q2 | $10.1K | Buy |
516
+323
| +167% | +$6.34K | ﹤0.01% | 3290 |
|
2024
Q1 | $4.19K | Sell |
193
-424
| -69% | -$9.2K | ﹤0.01% | 3559 |
|
2023
Q4 | $17.8K | Buy |
617
+94
| +18% | +$2.72K | ﹤0.01% | 3107 |
|
2023
Q3 | $14K | Sell |
523
-64
| -11% | -$1.71K | ﹤0.01% | 3033 |
|
2023
Q2 | $21.7K | Sell |
587
-112
| -16% | -$4.15K | ﹤0.01% | 2909 |
|
2023
Q1 | $21.8K | Buy |
699
+478
| +216% | +$14.9K | ﹤0.01% | 2939 |
|
2022
Q4 | $6.58K | Sell |
221
-199
| -47% | -$5.93K | ﹤0.01% | 3413 |
|
2022
Q3 | $16K | Sell |
420
-73
| -15% | -$2.78K | ﹤0.01% | 3130 |
|
2022
Q2 | $27K | Sell |
493
-408
| -45% | -$22.3K | ﹤0.01% | 2880 |
|
2022
Q1 | $56K | Buy |
901
+152
| +20% | +$9.45K | ﹤0.01% | 2557 |
|
2021
Q4 | $75K | Buy |
749
+317
| +73% | +$31.7K | ﹤0.01% | 2433 |
|
2021
Q3 | $39K | Sell |
432
-193
| -31% | -$17.4K | ﹤0.01% | 2755 |
|
2021
Q2 | $57K | Buy |
625
+278
| +80% | +$25.4K | ﹤0.01% | 2603 |
|
2021
Q1 | $33K | Sell |
347
-165
| -32% | -$15.7K | ﹤0.01% | 2772 |
|
2020
Q4 | $27K | Buy |
+512
| New | +$27K | ﹤0.01% | 2756 |
|
2020
Q3 | – | Sell |
-400
| Closed | -$6K | – | 3665 |
|
2020
Q2 | $6K | Buy |
+400
| New | +$6K | ﹤0.01% | 3172 |
|